We are supported by specialists

Curenetics is a fast-growing start-up with strong relationships

Collaboration is key to delivering the highest quality outcomes. We draw on the experience, resources, and advice of world experts from across multiple institutions. These partnerships provide valuable access to pioneering academic research, Ph.D. Studentships, and opportunities to develop ideas.

We welcome new relationships with like-minded organisations to accelerate our fight against cancer.

Our partners, supporters, and advisors

CureNx is our esteemed sister company in the US, specialising in the development and commercialisation of predictive models for immuno-oncologic therapy in lung and renal cancers, as well as melanoma.

They harness the power of multi-omics data and biomarker insights to create innovative AI-driven immuno-oncology markers. These markers enhance the certainty of positive treatment responses, ultimately improving patient outcomes.

Through CureNx, we expand our commitment to cutting-edge solutions in the fight against cancer, ensuring that patients around the world receive the most effective treatments based on the latest advancements in medical technology.